Accelerated Progression of Hepatocellular Carcinoma during Immunosuppressive Therapy with Abatacept for Rheumatoid Arthritis

Abatacept, a cytotoxic T lymphocyte antigen-4 immunoglobulin recombinant fusion protein, is an immunosuppressive agent indicated for rheumatoid arthritis. Although no significant increase in malignancy has been reported in abatacept-treated patients, whether or not abatacept accelerates tumor progre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Intern Med
Autors principals: Yoshiji, Satoshi, Takahashi, Ken, Sawada, Kenji, Mishima, Masako, Eso, Yuji, Morita, Masahiro, Takai, Atsushi, Marusawa, Hiroyuki, Ueda, Yoshihide, Mimori, Tsuneyo, Seno, Hiroshi
Format: Artigo
Idioma:Inglês
Publicat: The Japanese Society of Internal Medicine 2018
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6367098/
https://ncbi.nlm.nih.gov/pubmed/30146566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.0843-18
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars